![]() |
市場調查報告書
商品編碼
1466270
藥品物流市場:依運輸方式、產品、運輸、藥品供應階段 - 2024-2030 年全球預測Pharmaceutical Logistics Market by Mode of Transportation (Air Shipping, Rail Shipping, Road Shipping), Product (Biologic & Biosimilar, Branded Drugs, Generic Drugs), Transport, Drug Supply Stage - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年醫藥物流市場規模為696.8億美元,預計2024年將達731.2億美元,2030年將達999.4億美元,複合年成長率為5.28%。
藥品物流是對藥品、藥物和醫療產品從製造商到分銷商並最終到達患者的經銷商的管理。它涉及一系列協調的活動,如採購、裝卸、倉儲、分銷和運輸,同時確保產品的完整性、安全性和符合監管標準。我們的目標是按時、有效率、安全地將適當條件、適量的產品運抵目的地。同時,藥品溫控物流需求的不斷成長以及全球對疫苗和藥品需求的不斷成長正在推動藥品物流的成長。然而,與藥品物流相關的複雜流程和嚴格的政府法規為全球營運的公司帶來了重大挑戰。該公司繼續專注於開發更先進的低溫運輸解決方案、即時監控系統、無人機送貨到難以到達的地區以及永續包裝解決方案,以在全球格局中保持敏捷。此外,區塊鏈整合的進步可實現更好的可追溯性,使用人工智慧和資料分析進行預測性物流,以及確保溫度敏感產品有效性的溫控物流對於主要企業來說都是一個重要的機會。
主要市場統計 | |
---|---|
基準年[2023] | 696.8億美元 |
預測年份 [2024] | 731.2億美元 |
預測年份 [2030] | 999.4億美元 |
複合年成長率(%) | 5.28% |
運輸:更好的安全控制和可靠性將增加對空運和海運的偏好
醫藥物流精心策劃醫療產品安全、高效、合規的運輸。航空運輸對於時間敏感和高價值的藥品至關重要,並且由於其快速的運輸時間而經常被採用。航空運輸的優點是能夠在世界各地運輸物品並且延誤較少,但也正因為如此,它往往是一種重要的運輸方式。鐵路運輸是一種經濟有效的陸上大眾運輸解決方案,具有可靠的時間表和由於排放低於道路運輸而帶來的環境效益。另一方面,道路運輸反映了門到門交付的高度彈性。道路運輸對於機場和港口的運輸至關重要,是物流鏈的關鍵組成部分。海上運輸對於國際貿易至關重要,可實現低成本、大量的運輸。海上運輸是國際貿易的基石,可以以低成本運輸大量貨物。
藥品供應階段:利用內部和外包管理進行庫存管理,以滿足大小企業的需求。
自我管理使公司能夠直接控制其供應鏈,促進高品質和始終符合監管標準,並快速回應不斷變化的市場需求。透過選擇內部營運,公司可以更好地控制其供應鏈,確保滿足嚴格的監管和品質標準,並快速回應客戶需求。另一方面,外包給專業的物流提供者可以降低成本並提供專業的基礎設施、廣泛的網路和最尖端科技,簡化供應鏈並向市場交付關鍵藥物,您可以期待它更快。內部或外包物流的決定通常取決於公司的規模、資源的可用性以及藥品組合的複雜性,每種途徑都有自己的策略優勢。
區域洞察
在美洲,美國和加拿大因其龐大的消費市場、先進的醫療基礎設施以及全球製藥公司的強大影響力而成為重要的醫藥物流中心。對個人化醫療的需求不斷成長以及慢性病的高盛行率正在推動該地區對醫藥物流解決方案的需求。此外,由於監管情況的差異和基礎設施發展的需要,拉丁美洲新興市場的醫學物流多種多樣。同樣,歐盟 (EU) 的藥品物流領域也受到嚴格的監管,特別是在藥品安全和可追溯性方面。該地區需要在數位技術高度普及的推動下採用綜合物流解決方案來管理跨境藥品流動。同時,中東物流市場透過戰略地理位置和對空港、海港等基礎設施的投資而不斷成長。對高品質慢性病照護的需求不斷成長以及私人醫療機構的激增,需要快速而複雜的物流解決方案。此外,由於醫療產業的擴張、藥品製造的進步以及對醫療產品高效配送的需求不斷成長,亞太地區的藥品物流市場正在顯著成長。患者數量的增加、政府改善醫療基礎設施的努力以及製藥業對新興市場的日益關注是這一成長的關鍵驅動力。
FPNV定位矩陣
FPNV定位矩陣對於評估醫學物流市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對藥品物流市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,以獲得市場競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動以及突破性產品開發的見解。
1. 醫藥物流市場的市場規模與預測是多少?
2.醫藥物流市場預測期內我們應該考慮投資哪些產品與應用?
3. 醫藥物流市場的技術趨勢和法規結構是什麼?
4.醫藥物流市場主要供應商的市場佔有率為何?
5.進入醫藥物流市場的合適型態和策略手段是什麼?
[191 Pages Report] The Pharmaceutical Logistics Market size was estimated at USD 69.68 billion in 2023 and expected to reach USD 73.12 billion in 2024, at a CAGR 5.28% to reach USD 99.94 billion by 2030.
Pharmaceutical logistics is managing the flow of medicines, drugs, and healthcare products from manufacturers to distributors and ultimately to patients. It involves a series of coordinated activities, including procurement, handling, warehousing, distribution, and transportation, while ensuring the products' integrity, safety, and compliance with regulatory standards. The aim is to deliver the right products in the appropriate condition and quantity to the desired location on time, efficiently, and securely. Meanwhile, the growing need for temperature-controlled logistics for medicine and increased demand for vaccines and drugs worldwide has bolstered the growth of pharmaceutical logistics. However, the concerns associated with the complex process and the stringent government regulations related to pharmaceutical logistics present a significant challenge for companies operating in the global space. Companies are constantly focusing on developing more advanced cold chain solutions, real-time monitoring systems, drone delivery for inaccessible regions, and sustainable packaging solutions to remain agile within the global landscape. Moreover, the integration of blockchain for better traceability, the use of AI and data analytics for predictive logistics, and advancements in temperature-controlled logistics to ensure the efficacy of temperature-sensitive products are advent and present a significant opportunity for the key companies.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 69.68 billion |
Estimated Year [2024] | USD 73.12 billion |
Forecast Year [2030] | USD 99.94 billion |
CAGR (%) | 5.28% |
Mode of Transportation: Growing preference for air and sea shipping due to their better safety controls and reliability
Pharmaceutical logistics involves meticulous planning for the safe, efficient, and compliant transport of medical products. Air shipping is often employed for its rapid transit times, crucial for time-sensitive or high-value pharmaceuticals. It affords the advantage of global reach with minimal delays, though it tends to be the significant mode of transport. Rail shipping is a cost-effective solution for bulk shipments over land, providing reliable schedules and environmental benefits due to lower emissions than road transport. On the other hand, road shipping offers high flexibility for door-to-door deliveries. It is vital for the distribution to and from airports and seaports, making it an essential component of the logistics chain. Sea shipping is indispensable for international trade, offering the ability to move large volumes at a lower cost. It stands as a cornerstone for global commerce, capable of transporting substantial volumes at decreased costs.
Drug Supply Stage: Utilization of in-house and outsourced management for inventory control as per their need in large and SMEs
In-house management grants companies direct control over their supply chains, promoting consistent adherence to high quality and regulatory standards and nimbly responding to changes in market needs. Firms opt for in-house operations, capitalizing on greater control over their supply chains, ensuring that stringent regulatory and quality standards are uniformly met, and facilitating swift adaptation to customer demands. On the other hand, outsourcing to specialized logistics providers can offer cost savings and access to specialized infrastructure, expansive networks, and cutting-edge technology, which can streamline the supply chain and potentially expedite the delivery of critical drugs to the marketplace. The choice between in-house and outsourcing logistics often depends on a company's size, the availability of resources, and the complexity of its drug portfolio, each pathway presenting its own set of strategic advantages.
Regional Insights
In the Americas, the United States and Canada are significant hubs in pharmaceutical logistics due to their large consumer market, sophisticated healthcare infrastructure, and a strong presence of global pharmaceutical corporations. The increasing demand for personalized medicine and a high chronic disease prevalence rate drive the demand for pharmaceutical logistics solutions in this region. Additionally, emerging markets in Latin America present a varied pharmaceutical logistics landscape, affected by disparate regulatory systems and the need for infrastructure improvements. Similarly, the European Union's pharmaceutical logistics sector is governed by tight regulations, especially concerning drug safety and traceability. Integrated logistics solutions are in demand in this region, bolstered by the high penetration of digital technologies to manage cross-border pharmaceutical flows. On the other hand, The logistics market in the Middle East is experiencing growth through strategic geographic positioning and investments in infrastructure such as air and sea ports. There's a rising demand for high-quality chronic care medications and an increase in private healthcare facilities, requiring prompt and advanced logistics solutions. Moreover, the Asia-Pacific region is experiencing significant growth in the pharmaceutical logistics market, driven by the expanding healthcare sector, advancements in pharmaceutical manufacturing, and the increasing demand for efficient distribution of medical products. Factors such as a swelling patient pool, government initiatives to improve healthcare infrastructure, and a surge in the pharmaceutical industry's focus on emerging markets are key contributors to this growth.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include A.P. Moller - Maersk A/S, Air Canada, AIT Worldwide Logistics, Inc., Almac Group, AmerisourceBergen Corporation, AWL India Private Limited, Bilcare Limited, C.H. Robinson Worldwide, Inc., Catalent, Inc., CEVA Logistics, Clinigen Group PLC, Crown LSP Group, DHL International GmbH by Deutsche Post AG, DSV A/S, FedEx Corporation, ICON PLC, Infosys Limited, Kerry Logistics Network Limited, Kuehne + Nagel International AG, Lineage, Inc., Lonza Group Ltd., Movianto Group, NextPharma Logistics GmbH, Nippon Express Co., Ltd., Parexel International Corporation, SEKO Logistics, SF Express Co., Ltd., Thermo Fisher Scientific, Inc., United Parcel Service of America, Inc., and YUSEN LOGISTICS CO., LTD..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pharmaceutical Logistics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Logistics Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Logistics Market?
4. What is the market share of the leading vendors in the Pharmaceutical Logistics Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Logistics Market?